Wells Fargo & Company Bioventus Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Bioventus Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 14,882 shares of BVS stock, worth $167,273. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,882
Previous 256
5713.28%
Holding current value
$167,273
Previous $1,000
8400.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding BVS
# of Institutions
122Shares Held
41MCall Options Held
138KPut Options Held
137K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$146 Million24.48% of portfolio
-
Juniper Investment Company, LLC New York, NY6.83MShares$76.8 Million18.67% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.34MShares$60 Million2.05% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$26.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$18.7 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $693M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...